ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106557 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106557; 2) Community: the network communities that were significantly associated with the response to NSC 106557; 3) Molecule: the relationships between components within communities and NSC 106557; 4) MDR: the compounds that were significantly associated with the NSC 106557.

NSC Compound Enrichment Correlation
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.18585073
NSC 720495 Null 0.0237269271456697 0.13115947
NSC 732492 Null 0.0237269271456697 -0.087729606
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.0237269271456697 0.10723308
NSC 756401 GW832467X 0.0237269271456697 -0.29276505
NSC 758670 TANNIC ACID 0.0237269271456697 0.10398926
NSC 76455 Antibiotic from Streptomyces luteogriseus 0.0237269271456697 -0.02020007
NSC 608984 Leucinostatine D 0.0291420747327558 0.072263151
NSC 637209 Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) 0.0291420747327558 0.35650754
NSC 645018 1,4-bis(N-Cysteinyldiethylamino)-5,8-dihydroxy anthraquinon 0.0291420747327558 0.40719095
Total:42  Current:24    [First] [Prev] [Next] [Last]